BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 10699107)

  • 1. Early dexamethasone-attempting to prevent chronic lung disease.
    Sinkin RA; Dweck HS; Horgan MJ; Gallaher KJ; Cox C; Maniscalco WM; Chess PR; D'Angio CT; Guillet R; Kendig JW; Ryan RM; Phelps DL
    Pediatrics; 2000 Mar; 105(3 Pt 1):542-8. PubMed ID: 10699107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early postnatal dexamethasone therapy for the prevention of chronic lung disease in preterm infants with respiratory distress syndrome: a multicenter clinical trial.
    Yeh TF; Lin YJ; Hsieh WS; Lin HC; Lin CH; Chen JY; Kao HA; Chien CH
    Pediatrics; 1997 Oct; 100(4):E3. PubMed ID: 9310536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A three-day course of dexamethasone therapy to prevent chronic lung disease in ventilated neonates: a randomized trial.
    Garland JS; Alex CP; Pauly TH; Whitehead VL; Brand J; Winston JF; Samuels DP; McAuliffe TL
    Pediatrics; 1999 Jul; 104(1 Pt 1):91-9. PubMed ID: 10390266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicenter, randomized open study of early corticosteroid treatment (OSECT) in preterm infants with respiratory illness: comparison of early and late treatment and of dexamethasone and inhaled budesonide.
    Halliday HL; Patterson CC; Halahakoon CW;
    Pediatrics; 2001 Feb; 107(2):232-40. PubMed ID: 11158452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A controlled trial of dexamethasone to prevent bronchopulmonary dysplasia in surfactant-treated infants.
    Rastogi A; Akintorin SM; Bez ML; Morales P; Pildes RS
    Pediatrics; 1996 Aug; 98(2 Pt 1):204-10. PubMed ID: 8692619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized, placebo-controlled trial of human surfactant given at birth versus rescue administration in very low birth weight infants with lung immaturity.
    Merritt TA; Hallman M; Berry C; Pohjavuori M; Edwards DK; Jaaskelainen J; Grafe MR; Vaucher Y; Wozniak P; Heldt G
    J Pediatr; 1991 Apr; 118(4 Pt 1):581-94. PubMed ID: 2007937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two doses of early intravenous dexamethasone for the prevention of bronchopulmonary dysplasia in babies with respiratory distress syndrome.
    Sanders RJ; Cox C; Phelps DL; Sinkin RA
    Pediatr Res; 1994 Jul; 36(1 Pt 1):122-8. PubMed ID: 7936832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late Surfactant Administration in Very Preterm Neonates With Prolonged Respiratory Distress and Pulmonary Outcome at 1 Year of Age: A Randomized Clinical Trial.
    Hascoët JM; Picaud JC; Ligi I; Blanc T; Moreau F; Pinturier MF; Zupan V; Guilhoto I; Hamon IR; Alexandre C; Bouissou A; Storme L; Patkai J; Pomedio M; Rouabah M; Coletto L; Vieux R
    JAMA Pediatr; 2016 Apr; 170(4):365-72. PubMed ID: 26928567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial of moderately early low-dose dexamethasone therapy in very low birth weight infants: dynamic pulmonary mechanics, oxygenation, and ventilation.
    Durand M; Mendoza ME; Tantivit P; Kugelman A; McEvoy C
    Pediatrics; 2002 Feb; 109(2):262-8. PubMed ID: 11826205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dexamethasone effects on the hospital course of infants with bronchopulmonary dysplasia who are dependent on artificial ventilation.
    Kazzi NJ; Brans YW; Poland RL
    Pediatrics; 1990 Nov; 86(5):722-7. PubMed ID: 2235226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early inhaled glucocorticoid therapy to prevent bronchopulmonary dysplasia.
    Cole CH; Colton T; Shah BL; Abbasi S; MacKinnon BL; Demissie S; Frantz ID
    N Engl J Med; 1999 Apr; 340(13):1005-10. PubMed ID: 10099142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
    Bassler D
    Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of early dexamethasone administration on bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome.
    Tapia JL; Ramírez R; Cifuentes J; Fabres J; Hübner ME; Bancalari A; Mercado ME; Standen J; Escobar M
    J Pediatr; 1998 Jan; 132(1):48-52. PubMed ID: 9469999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early (4-7 days of age) dexamethasone therapy for prevention of chronic lung disease in preterm infants.
    Tsukahara H; Watanabe Y; Yasutomi M; Kobata R; Tamura S; Kimura K; Hiraoka M; Mayumi M
    Biol Neonate; 1999 Nov; 76(5):283-90. PubMed ID: 10516395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Follow-up at 15 years of preterm infants from a controlled trial of moderately early dexamethasone for the prevention of chronic lung disease.
    Gross SJ; Anbar RD; Mettelman BB
    Pediatrics; 2005 Mar; 115(3):681-7. PubMed ID: 15741372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicenter controlled clinical trial of high-frequency jet ventilation in preterm infants with uncomplicated respiratory distress syndrome.
    Keszler M; Modanlou HD; Brudno DS; Clark FI; Cohen RS; Ryan RM; Kaneta MK; Davis JM
    Pediatrics; 1997 Oct; 100(4):593-9. PubMed ID: 9310511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.
    Long W; Corbet A; Cotton R; Courtney S; McGuiness G; Walter D; Watts J; Smyth J; Bard H; Chernick V
    N Engl J Med; 1991 Dec; 325(24):1696-703. PubMed ID: 1944470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nasal CPAP or intubation at birth for very preterm infants.
    Morley CJ; Davis PG; Doyle LW; Brion LP; Hascoet JM; Carlin JB;
    N Engl J Med; 2008 Feb; 358(7):700-8. PubMed ID: 18272893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized Trial of 42-Day Compared with 9-Day Courses of Dexamethasone for the Treatment of Evolving Bronchopulmonary Dysplasia in Extremely Preterm Infants.
    Marr BL; Mettelman BB; Bode MM; Gross SJ
    J Pediatr; 2019 Aug; 211():20-26.e1. PubMed ID: 31349916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early Inhaled Budesonide for the Prevention of Bronchopulmonary Dysplasia.
    Bassler D; Plavka R; Shinwell ES; Hallman M; Jarreau PH; Carnielli V; Van den Anker JN; Meisner C; Engel C; Schwab M; Halliday HL; Poets CF;
    N Engl J Med; 2015 Oct; 373(16):1497-506. PubMed ID: 26465983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.